Suppr超能文献

阿霉素载入牛奶和间充质干细胞外泌体作为药物递送载体

Doxorubicin Loading into Milk and Mesenchymal Stem Cells' Extracellular Vesicles as Drug Delivery Vehicles.

作者信息

Mukhopadhya Anindya, Tsiapalis Dimitrios, McNamee Niamh, Talbot Brian, O'Driscoll Lorraine

机构信息

School of Pharmacy and Pharmaceutical Sciences, Panoz Institute, Trinity College Dublin, D02 PN40 Dublin, Ireland.

Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland.

出版信息

Pharmaceutics. 2023 Feb 21;15(3):718. doi: 10.3390/pharmaceutics15030718.

Abstract

Extracellular vesicles (EVs) have great potential as drug delivery vehicles. While mesenchymal/stromal stem cell (MSC) conditioned medium (CM) and milk are potentially safe and scalable sources of EVs for this purpose, the suitability of MSC EVs and milk EVs as drug delivery vehicles has never been compared and so was the objective of this study. Here EVs were separated from MSCs' CM and from milk and were characterised by nanoparticle tracking analysis, transmission electron microscopy, total protein quantification, and immunoblotting. An anti-cancer chemotherapeutic drug, doxorubicin (Dox), was then loaded into the EVs by one of three methods: by passive loading or by active loading by either electroporation or sonication. Dox-loaded EVs were analysed by fluorescence spectrophotometer, high-performance liquid chromatography (HPLC), and imaging flow cytometer (IFCM). Our study showed that EVs were successfully separated from the milk and MSC CM, with significantly ( < 0.001) higher yields of milk EVs/mL starting material compared to MSC EVs/mL of starting material. Using a fixed amount of EVs for each comparison, electroporation achieved significantly more Dox loading when compared to passive loading ( < 0.01). Indeed, of 250 µg of Dox made available for loading, electroporation resulted in 90.1 ± 12 µg of Dox loading into MSC EVs and 68.0 ± 10 µg of Dox loading into milk EVs, as analysed by HPLC. Interestingly, compared to the passive loading and electroporation approach, after sonication significantly fewer CD9+ EVs/mL ( < 0.001) and CD63+ EVs/mL ( < 0.001) existed, as determined by IFCM. This observation indicates that sonication, in particular, may have detrimental effects on EVs. In conclusion, EVs can be successfully separated from both MSC CM and milk, with milk being a particularly rich source. Of the three methods tested, electroporation appears to be superior for achieving maximum drug loading while not causing damage to EV surface proteins.

摘要

细胞外囊泡(EVs)作为药物递送载体具有巨大潜力。虽然间充质/基质干细胞(MSC)条件培养基(CM)和牛奶可能是用于此目的的潜在安全且可扩展的EVs来源,但从未比较过MSC EVs和牛奶EVs作为药物递送载体的适用性,这也是本研究的目的。在此,从MSC的CM和牛奶中分离出EVs,并通过纳米颗粒跟踪分析、透射电子显微镜、总蛋白定量和免疫印迹进行表征。然后,通过三种方法之一将一种抗癌化疗药物阿霉素(Dox)加载到EVs中:被动加载或通过电穿孔或超声处理进行主动加载。通过荧光分光光度计、高效液相色谱(HPLC)和成像流式细胞仪(IFCM)对加载了Dox的EVs进行分析。我们的研究表明,EVs已成功从牛奶和MSC CM中分离出来,与每毫升起始材料中的MSC EVs相比,每毫升起始材料中的牛奶EVs产量显著更高(<0.001)。在每次比较中使用固定量的EVs,与被动加载相比,电穿孔实现的Dox加载量显著更多(<0.01)。实际上,通过HPLC分析,在可用于加载的250μg Dox中,电穿孔导致90.1±12μg Dox加载到MSC EVs中,68.0±10μg Dox加载到牛奶EVs中。有趣的是,与被动加载和电穿孔方法相比,超声处理后通过IFCM测定,每毫升CD9 + EVs(<0.001)和每毫升CD63 + EVs(<0.001)的数量显著减少。这一观察结果表明,尤其是超声处理可能会对EVs产生有害影响。总之,EVs可以成功地从MSC CM和牛奶中分离出来,牛奶是特别丰富的来源。在测试的三种方法中,电穿孔似乎在实现最大药物加载量的同时不会对EV表面蛋白造成损害方面表现更优。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be5b/10051717/7fee7d43790d/pharmaceutics-15-00718-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验